Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
-
Disgraced crypto mogul Do Kwon changes plea to guilty in US court
-
Frank confident Spurs will be 'incredibly competitive' against PSG
-
Gaza mediators 'working very hard' to revive truce plan: Egypt
-
Man City's Grealish joins Everton on season-long loan
-
Ukraine says fighting 'difficult' after reports of Russia's rapid gains
-
US consumer inflation holds steady but tariff risks persist
-
Two killed in European wildfires as heatwave intensifies
-
S.Africa to offer US new deal to avoid 30% tariff
-
Gambia baby death heightens alarm over female genital mutilation
-
Soldier dies battling Montenegro wildfire
-
Last Liverpool goal had special meaning for Jota
-
Mixed crews introduced for 2027 America's Cup
-
Stocks rise on restrained US inflation
-
US consumer inflation holds steady but tariff worries persist
-
Brevis smashes record ton as South Africa level T20 series
-
EU ready to do plastic pollution deal 'but not at any cost'
-
China Evergrande Group says to delist from Hong Kong
-
In China's factory heartland, warehouses weather Trump tariffs
-
Palace claim sporting merit 'meaningless' after Europa League demotion
-
Former Premier League referee Coote given eight-week ban over Klopp comments
-
Council of Europe cautions on weapon sales to Israel
-
The Elders group of global leaders warns of Gaza 'genocide'
-
Stocks gain on China-US truce, before key inflation data
-
Man killed in Spain wildfire as European heatwave intensifies
-
US, China extend tariff truce for 90 days
-
Families mourn 40 years since deadly Japan Airlines crash
-
Thai soldier wounded in Cambodia border landmine blast
-
PSG sign Ukrainian defender Illia Zabarnyi from Bournemouth
-
PSG sign Ukrainian defender Illia Zabarnyi
-
Five Premier League talking points
-
Five talking points as Spain's La Liga begins
-
Markets boosted by China-US truce extension, inflation in focus
-
Japan boxing to adopt stricter safety rules after deaths of two fighters
-
France adopts law upholding ban on controversial insecticide
-
Most markets rise as China-US truce extended, inflation in focus
-
Toll of India Himalayan flood likely to be at least 70
-
Taylor Swift announces 12th album for 'pre pre-order'
-
Italian athlete dies at World Games in China
-
AI porn victims see Hong Kong unprepared for threat
-
Two dead, 10 hospitalized in Pennsylvania steel plant explosions
-
Steely Sinner advances amid Cincinnati power-failure chaos
-
Families forever scarred 4 years on from Kabul plane deaths
-
Scientists find 74-million-year-old mammal fossil in Chile
-
Trump signs order to extend China tariff truce by 90 days
-
Spanish police bust 'spiritual retreat' offering hallucinogenic drugs
-
Jellyfish force French nuclear plant shutdown
-
Dr. Roy Levitt, Executive Chairman of Adolore BioTherapeutics, Presented at the Next Generation Gene Therapy Vectors Summit
-
InHand Networks Introduces the CPE02: Powering Business Networks with High-Speed Connectivity and Smart Management
-
Soil Action Raises $5.25M to End the Guesswork Beneath the Surface
-
VSee Health Appeals NASDAQ Staff Delisting Notice
NYSE - LSE
| RBGPF | 0% | 73.08 | $ | |
| RYCEF | 2.45% | 14.7 | $ | |
| CMSC | 0.04% | 23.07 | $ | |
| CMSD | -0.02% | 23.565 | $ | |
| VOD | 0.46% | 11.563 | $ | |
| SCS | 2% | 16.285 | $ | |
| SCU | 0% | 12.72 | $ | |
| GSK | 1.17% | 38.155 | $ | |
| AZN | 1.13% | 74.92 | $ | |
| RELX | -0.58% | 47.765 | $ | |
| BCC | 4.45% | 84.5 | $ | |
| BTI | -0.41% | 58.09 | $ | |
| BCE | 1.3% | 24.67 | $ | |
| RIO | 1.75% | 63.25 | $ | |
| JRI | -0.22% | 13.36 | $ | |
| NGG | -1.33% | 70.295 | $ | |
| BP | 0.96% | 34.28 | $ |
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
HACKENSACK, NJ / ACCESS Newswire / July 21, 2025 / Champions Oncology, Inc. (CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, will report its financial and operational results for the quarter and year ended April 30, 2025, on Wednesday, July 23, 2025, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EDT (1:30 P.M. PDT). To join the call dial 888-506-0062 (Domestic) or 973-528-0011 (International) and enter the access code 792442. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 52754, or by accessing the investors section of the company's website within 72 hours.
About Champions Oncology, Inc.
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platform and analytics, and scientific excellence, Champions enables the advancement of preclinical and clinical oncology drug discovery and development programs worldwide. For more information, please visit www.ChampionsOncology.com.
Media Inquiries:
Gavin Cooper
Vice President, Global Marketing
[email protected]
Website: https://www.championsoncology.com/
Facebook: https://www.facebook.com/championsoncology/
LinkedIn: https://www.linkedin.com/company/champions-oncology-inc-/
Twitter: @ChampionsOncol1
Instagram: https://www.instagram.com/championsoncology/
SOURCE: Champions Oncology, Inc.
View the original press release on ACCESS Newswire
P.M.Smith--AMWN